Ca2+ channel inhibitor
Blocks slow voltage-sensitive L-type Ca2+ channels. Adrenergic antagonist. Inhibits platelet-activating factor and PMA-stimulated prostaglandin production in Kupffer cells. Induces apoptosis. In vitro resistance modifier in drug resistant human tumor cell lines.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
5-[(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropyl-valeronitrile . HCl |
---|---|
Appearance |
White crystalline powder. |
CAS |
152-11-4 |
Couple Target |
Calcium channel |
Couple Type |
Inhibitor |
Formula |
C27H38N2O4 . HCl |
Identity |
Determined by IR. |
MI |
14: 9950 |
MW |
454.6 . 36.5 |
Purity |
≥99% (HPLC) |
RTECS |
YV8320000 |
Solubility |
Soluble in 100% ethanol (26mg/ml), methanol or water (83mg/ml). |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. |
---|---|
Long Term Storage |
Ambient |
Shipping |
Ambient Temperature |
Regulatory Status |
RUO – Research Use Only |
---|
- In vitro assessment of the inhibitory effect of goreisan extract and its ingredients on the P-glycoprotein drug transporter and cytochrome P-450 metabolic enzymes: M. Takiyama, et al.; Xenobiotica 52, 511 (2022), Abstract
- Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells: W. C. Chen, et al.; Nat. Commun. 12, 4288 (2021), Abstract
- Pharmacokinetic study of Ninjin’yoeito: Absorption and brain distribution of Ninjin’yoeito ingredients in mice: T. Matsumoto, et al.; J. Ethnopharmacol. 279, 114332 (2021), Abstract
- Regulation of i>KRAS4A/B/i> splicing in cancer stem cells by the RBM39 splicing complex: Chen, W., To, M. D., et al.; bioRxiv , (2019)
- Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer: Morad, S. A. F., Davis, T. S., et al.; Biochem. Pharmacol. 130, 21 (2017), Abstract
- Short-term exposure to L-type calcium channel blocker, verapamil, alters the expression pattern of calcium-binding proteins in the brain of goldfish, Carassius auratus: N.V. Palande, et al.; Comp. Biochem. Physiol. C: Tocicol. Pharmacol. 176-177, 31 (2015), Application(s): Cell culture in fish, Abstract
- Overnutrition induces β-cell differentiation through prolonged activation of β-cells in zebrafish larvae: Li, M., Maddison, L. A., et al.; Am. J. Physiol. Endocrinol. Metab. 306, E799 (2014), Abstract
- Angiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1: Baskin, R., Sayeski, P. P., et al.; Cell. Signal. 24, 435 (2012), Abstract
- Hyperthermia and verapamil inhibit the growth of human colon cancer xenografts in vivo through apoptosis: I.B. Shchepotin, et al.; Anticancer Res. 17, 2213 (1997), Abstract
- Neuron degeneration induced by verapamil and attenuated by EGb761: L. Zhu, et al.; J. Basic Clin. Physiol. Pharmacol. 8, 301 (1997), Abstract
- Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line: I.B. Shchepotin, et al.; Int. J. Hyperthermia 13, 547 (1997), Abstract
- Effect of high-dose verapamil administration on the Ca2+ channel density in rat cardiac tissue: B.B. Lonsberry, et al.; Pharmacology 49, 23 (1994), Abstract
- Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitro induced by 5-fluorouracil, verapamil, and hyperthermia: I.B. Shchepotin, et al.; Anticancer Res. 14, 1027 (1994), Abstract
- Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex: D. Piwnica-Worms, et al.; Cancer Res. 53, 977 (1993), Abstract
- : Goodman and Gilman’s The Pharmacological Basis of Therapeutics, vol. 8; , p. 774 (1990)
- Drug action and cellular calcium regulation: R. Janis, et al.; Adv. Drug Res. 16, 309 (1987)
- Participation of intracellular sites in the action of Ca2+ channel blockers: E.J. White & H.F. Bradford; Eur. J. Pharmacol. 130, 243 (1986), Abstract
- The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site: R.H. Zobrist, et al.; J. Mol. Cell. Cardiol. 18, 963 (1986), Abstract
- Calcium antagonism and calcium entry blockade: T. Godfraind, et al.; Pharmacol. Rev. 38, 321 (1986), Abstract
- Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase: O. Scharff & B. Foder; Biochim. Biophys. Acta 772, 29 (1984), Abstract
Related Products

CAS | 38966-21-1 |
---|---|
Couple Type | Inhibitor |
Purity | ≥98% (TLC) |

Alternative Name | D-Bicuculline |
---|---|
CAS | 485-49-4 |
Couple Type | Inhibitor, Ligand |
Purity | ≥98% (HPLC) |

Alternative Name | (+)-3,3’,4’,5,7-Flavanpentol . H2O |
---|---|
CAS | 225937-10-0 |
Purity | ≥98% (HPLC) |

Alternative Name | 6-(6-Methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,8-dihydrofuro[3,4-E][1,3]benzodioxol-8-ol, (+)-Decumbensine |
---|---|
CAS | 6883-44-9 |
Purity | ≥98% (HPLC) |
Last modified: May 29, 2024
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form